PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,807,000 | +89.2% | 169,066 | +66.3% | 0.20% | +70.4% |
Q4 2014 | $955,000 | -29.0% | 101,686 | -42.0% | 0.12% | -19.6% |
Q3 2014 | $1,346,000 | -63.1% | 175,261 | -56.8% | 0.14% | -59.4% |
Q2 2014 | $3,646,000 | +53.5% | 405,980 | -8.6% | 0.35% | +46.1% |
Q1 2014 | $2,375,000 | – | 443,970 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sageview Capital | 2,223,339 | $5,603,000 | 1.59% |
Orbimed Advisors | 2,320,800 | $5,848,000 | 0.09% |
F&C Asset Management plc | 1,854,808 | $4,665,000 | 0.06% |
SPHERA FUNDS MANAGEMENT LTD. | 56,500 | $142,000 | 0.04% |
Yakira Capital Management, Inc. | 11,957 | $30,000 | 0.03% |
Spectrum Management Group, LLC | 10,000 | $25,000 | 0.02% |
Weiss Multi-Strategy Advisers LLC | 41,152 | $104,000 | 0.00% |
WOLVERINE ASSET MANAGEMENT LLC | 30,000 | $75,000 | 0.00% |
PUTNAM INVESTMENTS LLC | 129,762 | $327,000 | 0.00% |
Partnervest Advisory Services LLC | 220 | $1,000 | 0.00% |